← Leaderboards
Eyal C Attar
Massachusetts General Hospital
$711,990
Attributed
$711,990
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $143.4K · FY2007–11$200K$150K$100K$50K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$711,990 · 1
By mechanism
K23$711,990 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- John H Growdon$11,829,523
- E. Antonio Chiocca$34,514,665
- Harland S Winter$1,653,812
- Merit E Cudkowicz$97,012,119
- Alan J Fischman$7,064,039
Others in their field
Top investigators on “Elderly”
- Charles A Coltman · Southwest Oncology Group$158,376,564
- Richard L Schilsky · University Of Chicago$122,071,723
- Michael W Weiner · Northern California Institute Res &Educ$99,760,701
- Monica M Bertagnolli · Strang Cancer Prevention Center$99,246,201
- Richard Mayeux · Columbia University Health Sciences$83,247,500
- Peter Gordon Gillespie · Oregon Health And Science University$80,983,248
Research focus
ElderlyDisease RemissionDisease-Free SurvivalDoseBone MarrowBaseAdvisory CommitteesBiologicalDiagnosisCellsCessation Of LifeChemotherapyChemotherapy-Oncologic ProcedureBortezomibClinical EfficacyCareerClinical ResearchClinical TrialsCell LineApoptoticCollaborationsCytarabineCytotoxicityEnsure
Grant awards (5)
Defining clinical efficacy and markers predicting response to bortezomib in AML$143,370
K23 · FY2011 · CA · contact PI
Defining clinical efficacy and markers predicting response to bortezomib in AML$143,370
K23 · FY2010 · CA · contact PI
Defining clinical efficacy and markers predicting response to bortezomib in AML$142,560
K23 · FY2009 · CA · contact PI
Defining clinical efficacy and markers predicting response to bortezomib in AML$141,750
K23 · FY2008 · CA · contact PI
Defining clinical efficacy and markers predicting response to bortezomib in AML$140,940
K23 · FY2007 · CA · contact PI